The benefits, costs and feasibility of a low incidence COVID-19 strategy
| العنوان: | The benefits, costs and feasibility of a low incidence COVID-19 strategy |
|---|---|
| المؤلفون: | Thomas Czypionka, Emil N. Iftekhar, Barbara Prainsack, Viola Priesemann, Simon Bauer, André Calero Valdez, Sarah Cuschieri, Enrico Glaab, Eva Grill, Jenny Krutzinna, Christos Lionis, Helena Machado, Carlos Martins, George N. Pavlakis, Matjaž Perc, Elena Petelos, Martyn Pickersgill, Alexander Skupin, Eva Schernhammer, Ewa Szczurek, Sotirios Tsiodras, Peter Willeit, Paul Wilmes |
| المساهمون: | Czypionka, Thomas [0000-0002-3381-1075], Prainsack, Barbara [0000-0002-6335-1532], Glaab, Enrico [0000-0003-3977-7469], Apollo - University of Cambridge Repository, European Commission - EC [sponsor], Fonds National de la Recherche - FnR [sponsor], Luxembourg Centre for Systems Biomedicine (LCSB) [research center] |
| المصدر: | The Lancet Regional Health-Europe The Lancet Regional Health. Europe, Vol 13, Iss, Pp 100294-(2022) The lancet / Regional health / Europe 13, 100294 (2022). doi:10.1016/j.lanepe.2021.100294 info:eu-repo/grantAgreement/EC/H2020/115910 |
| بيانات النشر: | RWTH Aachen University, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Immunology & infectious disease [D12] [Human health sciences], COVID-19 (Disease) -- Vaccination, Studier av offentlig förvaltning, 32 Biomedical and Clinical Sciences, Multidisciplinary, general & others [F99] [Life sciences], COVID-19 Pandemic, 2020, containment, Vaccine Related, Multidisciplinaire, généralités & autres [F99] [Sciences du vivant], COVID-19 (Disease) -- Safety measures, Internal Medicine, ddc:610, non-pharmaceutical interventions, 3202 Clinical Sciences, SARS-CoV-2, Public Administration Studies, pandemic, Prevention, Health Policy, COVID-19, 3 Good Health and Well Being, COVID-19 (Disease) -- Prevention, Immunologie & maladie infectieuse [D12] [Sciences de la santé humaine], 50 Philosophy and Religious Studies, Oncology, COVID-19 (Disease) -- Government policy, Public health strategies, Public aspects of medicine, RA1-1270 |
| الوصف: | In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have ranged from countries aiming at low incidence by re-introducing NPIs to accepting high incidence levels. However, such high incidence strategies almost certainly lead to the very consequences that they seek to avoid: restrictions that harm people and economies. At high incidence, the important pandemic containment measure ‘test-trace-isolate-support’ becomes inefficient. At that point, the spread of SARS-CoV-2 and its numerous harmful consequences can likely only be controlled through restrictions. We argue that all European countries need to pursue a low incidence strategy in a coordinated manner. Such an endeavour can only be successful if it is built on open communication and trust. peer-reviewed |
| وصف الملف: | application/pdf |
| اللغة: | English |
| DOI: | 10.18154/rwth-2022-04145 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07667d1c693fe526c331ccc38157c3caTest |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....07667d1c693fe526c331ccc38157c3ca |
| قاعدة البيانات: | OpenAIRE |
| DOI: | 10.18154/rwth-2022-04145 |
|---|